CLINICAL_TRIALS ClinicalTrials.gov record update

Feasibility Trial of MK3475 + Docetaxel or Gemcitabine in Platinum Pre-treated Urothelial Cancer

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT02437370
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:38:57.364230+00:00
Published At: 2022-10-18T00:00:00+00:00
Record Updated At: 2022-10-18
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Metastatic Urothelial Carcinoma of the Renal Pelvis and Ureter", "Recurrent Bladder Carcinoma", "Recurrent Urothelial Carcinoma of the Renal Pelvis and Ureter", "Regional Urothelial Carcinoma of the Renal Pelvis and Ureter", "Stage III Bladder Urothelial Carcinoma", "Stage III Urethral Cancer", "Stage IV Bladder Urothelial Carcinoma", "Stage IV Urethral Cancer", "Urethral Urothelial Carcinoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2022-10-18"
protocolSection.identificationModule.nctId: "NCT02437370"
protocolSection.identificationModule.officialTitle: "Feasibility Trial of MK3475 + Docetaxel or Gemcitabine in Platinum Pre-treated Urothelial Cancer"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.